A new thermometer takes the temperature of objects by sensing sounds that the objects give off when they get hot. In this simulation, a sheet of silicon nitride (center) detects sound waves from hot blobs of epoxy (ovals at top, bottom, left and right).
This robot is smaller than the width of a hair đ€Ż And scientists hope it will be used to hunt down and destroy cancer cells.
Austin startup Lift Aircraft calls Hexa, its electric vertical takeoff and landing (eVTOL) aircraft the future of personal flight. So far, itâs been compared to a drone and a flying car.
Hexa is essentially a recreational vehicle for the air, able to fly in 15-minute intervals at low altitudes. Lift plans to market them to millennials with disposable income and anyone chasing adrenaline, because a pilotâs license isnât required. The COVID-19 pandemic delayed plans, but Lift still says it will be touring locations across the US where anyone meeting height, weight, and age requirements can pay to fly. As of November 2019, Lift says it had more than 15,000 flights on a waitlist to ride Hexa.
The company is also selling a small number of Hexas to buyers who will then rent them out. They cost $495,000, and only five are still available.
Drone solution provider MissionGO has completed the longest organ delivery by drone in Las Vegas last week with the Nevada Donor Network. The two test flights were carrying a human organ and tissue to various locations around Las Vegas.
The first of the two flights was transporting research corneas from the Southern Hills Hospital and Medical Center to Dignity Health at the St. Rose Dominican, San MartĂn Campus. The flight demonstrated the viability, value, efficiency gains, and delivery speed of using drones to deliver organs and medical supplies.
The second flight delivered a research kidney from an airport to a location on the outskirts of a small town in the Las Vegas desert. This second flight was the one that marked the longest organ delivery by drone. The flight beat the previous record that was set in April 2019 also by MissionGO.
Researchers identified some of the most potent and diverse antibodies discovered to date that neutralize SARS-CoV-2, targeting multiple regions on the viral spike.
LEAF president Keith Comito explains the story of Lifespan.io â a crowdsourcing platform and community to support biomedical research aimed at extending healthy human lifespan.
âŒâŒ More info and links below âŒâŒ
HOW CAN YOU SUPPORT US?
ââââââââââââââââââââââââââ
LEAF / Lifespan.io is a 501©(3) nonprofit organization. Everything weâve done thus far and everything we will do in the future is thanks to your support â please stand with us to fight the diseases of aging and increase healthy human lifespan.
âș Support us with monthly donations by becoming a Lifespan Hero: https://www.lifespan.io/hero
âș Make a one-time donation and learn about other ways to support us here: http://lifespan.io/support
âș Learn more, and help us #CrowdsourceTheCure: https://www.lifespan.io
âș Subscribe: https://www.youtube.com/user/LifespanIO?sub_confirmation=1
THANKS TO THE SUPPORT OF PEOPLE LIKE YOU, WE HAVE:
Psilocybin startup Compass Pathways goes public at more than $1B. Hereâs why Wall Street is starting to see the value in psychedelics.
For several years, investors and psychonauts have predicted that psychedelic medicine would become the next billion-dollar industry, with some value estimates as high as $100 billion. They said substances like MDMA or psilocybin mushrooms would follow a similar regulatory path that cannabis took to the mainstream, going from a Schedule 1 narcotic to a legal, regulated, and highly lucrative medicine.
At least some of these predictions have rung true. On September 18th, Compass Pathways Plc., a London-based company developing psilocybin into a prescription drug in assisted psychotherapy, went public, listing on Nasdaq. The companyâs stock jumped 71 percent on its first day of trading and is now estimated to be worth $1.3 billion. Compass Pathways declined to comment for this article. Numinus Wellness Inc and Champignon Brands Inc are two other psychedelic companies that have gone public this year.
Psilocybin startup Compass Pathways goes public at more than $1B. Hereâs why Wall Street is starting to see the value in psychedelics.
For several years, investors and psychonauts have predicted that psychedelic medicine would become the next billion-dollar industry, with some value estimates as high as $100 billion. They said substances like MDMA or psilocybin mushrooms would follow a similar regulatory path that cannabis took to the mainstream, going from a Schedule 1 narcotic to a legal, regulated, and highly lucrative medicine.
At least some of these predictions have rung true. On September 18th, Compass Pathways Plc., a London-based company developing psilocybin into a prescription drug in assisted psychotherapy, went public, listing on Nasdaq. The companyâs stock jumped 71 percent on its first day of trading and is now estimated to be worth $1.3 billion. Compass Pathways declined to comment for this article. Numinus Wellness Inc and Champignon Brands Inc are two other psychedelic companies that have gone public this year.Bâ | >
Stem cells are a promising experimental treatment for a variety of diseases. Now researchers at the University of Wisconsin-Madison have found that transplanting neurons grown from stem cells into the brains of mice with Parkinsonâs disease repaired the damaged brain circuits, improving the animalsâ motor skills.
In people afflicted with Parkinsonâs, neurons that produce dopamine begin to break down and die. The disease gradually presents as tremors, involuntary movements, and trouble with walking, speaking and other actions. While it currently canât be cured, studies are suggesting new ways to slow progression and reduce severity of symptoms through new drugs or repurposed old ones, deep brain stimulation or probiotic treatments.
But an emerging and potentially ground-breaking treatment involves stem cells. In several studies, researchers have used stem cells to grow new dopamine-producing neurons, and then transplant them into animals. And now the UW-Madison teamâs work has shown that doing so can help restore brain circuits damaged by Parkinsonâs.
Posted in biotech/medical
This video explains the structural forms of DNA, why DNA have different forms and what are the differences present between each form.
Thank You For Watching.
Please Like And Subscribe to Our Channel: https://www.youtube.com/EasyPeasyLearning
Like Our Facebook Page: https://www.facebook.com/learningeasypeasy/
Join Our Facebook Group: https://www.facebook.com/groups/460057834950033
